
The FDA Just Bypassed Its Own Queue
A new regulatory fast-track for cancer software signals a major shift in how medical AI will evolve after entering the clinic.
Discover the newest research about AI innovations in π Oncology.

A new regulatory fast-track for cancer software signals a major shift in how medical AI will evolve after entering the clinic.

A new artificial intelligence model can classify gastric biopsies and predict lymph node spread, significantly cutting pathologist workloads without sacrificing accuracy.

When commercial software cannot keep pace with clinical reality, health systems are forced to become software developers.

A new study reveals that while AI easily spots prostate cancer across different imaging hardware, the actual grading of those tumors falls apart depending on which scanner a hospital uses.

Regulators are forcing a public reckoning over whether marginal cancer screening benefits justify the risks of widespread adoption.

Automating ultrasound analysis could finally break the bottleneck in breast cancer screening.

A new AI model predicts kidney cancer survival better than the gold-standard human grading system.

A new machine learning model tackles the biological noise threatening to derail non-invasive cancer testing.

A patient’s fate is often hidden in the messy paragraphs of their medical charts rather than their official disease stage.

Algorithms can now flag the earliest signs of lung cancer, but technology alone cannot fix a broken healthcare pipeline.